vimarsana.com
Home
Live Updates
Svas Biosana S p A : The Board of Directors of SVAS Biosana approves the short-form consolidated half-yearly financial statements as at 30 june 2023 -September 27, 2023 at 05:38 am EDT : vimarsana.com
Svas Biosana S p A : The Board of Directors of SVAS Biosana approves the short-form consolidated half-yearly financial statements as at 30 june 2023 -September 27, 2023 at 05:38 am EDT
EBITDA Margin 12.6%
Consolidated EBIT: €4.2 million - EBIT Margin 7.7%
Consolidated Net Profit: €2.3 million
...
Related Keywords
Milan ,
Lombardia ,
Italy ,
Ukraine ,
Slovenia ,
Russia ,
Bolzano ,
Trentino Alto Adige ,
Croatia ,
Serbia ,
Somma Vesuviana ,
Campania ,
Santagostino ,
Emilia Romagna ,
San Giuseppe Vesuviano ,
Trentola ,
Rome ,
Lazio ,
Italian ,
Russian ,
Ukrainian ,
Umberto Perillo ,
Borsa Italiana ,
Banca Profilo ,
Andrea Efficace ,
Svas Biosana ,
Sves Biosana ,
Svas Biosana Group ,
Ministry Of Health ,
Bormia Group ,
Companies Register ,
Group Net Financial Position ,
Development Department ,
Investor Relations Press ,
Ministry Of Economy ,
National Health Fund ,
Net Profit ,
Net Financial Position ,
Euronext Growth Milan ,
Giuseppe Vesuviano ,
Farmex Business Unit ,
Mark Medical Business Unit ,
Eastern Europe ,
Gross Operating Margin ,
Operating Profit ,
Aiuti Bis Decree ,
Decree Law ,
Official Journal ,
Medical Device Payback ,
Italian Government ,
Civil Code ,
Mark Medical ,
Euronext Growth Milan Issuer Regulations ,
Press Releases ,
Investor Relations Manager ,
Markets ,
vimarsana.com © 2020. All Rights Reserved.